432 St Kilda Road
Suite 1, Level 9
Melbourne, VIC 3004
Australia
61 3 9653 9160
https://respiri.co
Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Nicholas Smedley | Executive Chairman | 245,46k | N/A | N/A |
Mr. Marjan Mikel B.Sc., M.A.I.C.D. | CEO, MD & Executive Director | 453,6k | N/A | N/A |
Mr. Peter Hildebrandt | Chief Operations Officer | 259,68k | N/A | N/A |
Mr. George Vlachodimitropoulos | Chief Technology Officer | 275,29k | N/A | N/A |
Dr. Samaneh Sarraf Shirazi | Chief Research Officer | 194,99k | N/A | N/A |
Mr. Theo Antonopoulos | Chief Commercial Officer | 300,29k | N/A | N/A |
Mr. William Sigsbee | Head of US Operations & Chief Commercial Officer | N/A | N/A | N/A |
Mr. Justin Mouchacca B.Bus (Acc), C.A., CA | Joint Company Secretary | N/A | N/A | N/A |
Ms. Nova Anne Taylor | Joint Company Secretary | N/A | N/A | N/A |
Prof. Noam Gavriely | Medical & Scientific Advisor | 191,61k | N/A | N/A |
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company is based in Melbourne, Australia.
Respiri Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.